We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Abbott Targets Amneal in Latest Fight Over Generic Niaspan
Abbott Targets Amneal in Latest Fight Over Generic Niaspan
September 4, 2012
Abbott Laboratories’ AbbVie hit Amneal Pharmaceuticals with a patent suit in Delaware Federal Court, arguing that Amneal has infringed a patent covering its cholesterol medication, Niaspan. Law360
